sb 203580 has been researched along with lamivudine in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (lamivudine) | Trials (lamivudine) | Recent Studies (post-2010) (lamivudine) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 7,025 | 1,425 | 2,177 |
Protein | Taxonomy | sb 203580 (IC50) | lamivudine (IC50) |
---|---|---|---|
Capsid protein | Hepatitis B virus | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, W; Wu, L; Yu, G; Zhang, X; Zhao, X | 1 |
1 other study(ies) available for sb 203580 and lamivudine
Article | Year |
---|---|
Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro.
Topics: Antiviral Agents; Aquatic Organisms; Butadienes; DNA Replication; DNA, Viral; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Imidazoles; Interferon-beta; Lamivudine; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Polysaccharides; Protein Kinase Inhibitors; Pyridines; RNA, Viral; Sulfones; Virus Replication | 2016 |